Skip to main content

Month: September 2021

New Applied Materials Technologies Help Leading Silicon Carbide Chipmakers Accelerate the Transition to 200mm Wafers and Increase Chip Performance and Power Efficiency

Applied Materials’ silicon carbide-optimized Mirra® Durum™ CMP SystemTo help enable the silicon carbide chip industry’s move to larger, 200mm wafers, Applied Materials introduced the Mirra® Durum™ CMP system. It produces uniform SiC wafers with the highest quality surfaces by integrating polishing, materials removal measurement, cleaning and drying in a single system.Applied Materials’ silicon carbide-optimized VIISta® 900 3D Hot Ion Implant SystemApplied Materials’ new VIISta® 900 3D hot ion implant system injects and diffuses ions into 200mm and 150mm silicon carbide wafers, delivering a more than 40X reduction in resistivity compared to room temperature implant.Key to the world’s best electric vehicle power trains, silicon carbide chips are transitioning to larger, 200mm wafers which boost output to...

Continue reading

Osino Announces Filing of Mining License Application For Twin Hills Gold Project, Namibia

HighlightsApplication for Mining License (“ML”) filed with Namibia’s Ministry of Mines and Energy Osino is fast-tracking the necessary specialist studies to progress and conclude the Twin Hills mine permitting process in accordance with Namibia’s regulatory process Environmental baseline studies nearing completion Formal public participation process and stakeholder engagement underwayVANCOUVER, British Columbia, Sept. 08, 2021 (GLOBE NEWSWIRE) — Osino Resources Corp. (TSXV:OSI) (FSE:RSR1) (OTCQX:OSIIF) (“Osino” or “the Company”) is pleased to announce that it has filed an application with Namibia’s Ministry of Mines and Energy for a mining license at its flagship Twin Hills Gold Project (“Twin Hills” or “the Project”) in Namibia. The application comes after the Company released a Preliminary Economic Assessment (“PEA”)...

Continue reading

Ecoark Secures Power Capacity for Cryptocurrency Mining Beta Site Development in Texas

First Phase Expected to Become Operational in approximately 90 days SAN ANTONIO, Sept. 08, 2021 (GLOBE NEWSWIRE) — Ecoark Holdings, Inc. (“Ecoark”) (NASDAQ: ZEST), announced that its indirect wholly owned subsidiary Bitstream Mining LLC (“Bitstream”), a wholly owned subsidiary of Trend Discovery Holdings LLC (“Trend”) entered into an agreement on September 3, 2021, to secure 12 MW (“megawatts”) of available electric capacity for Bitstream’s mining operation. Specific terms of the agreement will be disclosed at a future date. Bitstream and its strategic power consultant are working with the utility to upgrade the utility’s substation in order to expand the available capacity up to 50 MW.    Ecoark previously announced that Bitstream would be developing a 6 MW cryptocurrency mining operation in Texas. Brad Hoagland, CFA, Chief Financial...

Continue reading

Qualigen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

CARLSBAD, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) — Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with potential for Orphan Drug Designation, announced today that CEO and Chairman Michael Poirier will present at the H.C. Wainwright 23rd Annual Global Investment Conference September 13-15, 2021. The presentation will provide an overview of the Company’s strategy focusing primarily on its oncology drug pipeline which includes QN-247 and RAS-F assets for which Qualigen has already seen encouraging preclinical data. Details for this presentation are as follows: Conference name: H.C. Wainwright 23rd Annual Global Investment Conference Format: Virtual Presentation Webcast: www.qualigeninc.com/hcw2021Presentation Time: Webcast is viewable beginning...

Continue reading

Gain Therapeutics, Inc. Announces Positive Topline Data in Patient-derived iPSC Study Evaluating STAR Compounds as a Treatment for Gaucher and Parkinson’s Disease

GT-02287and GT-02329 compounds display positive effects on GCase activity and related parameters— Study results demonstrate an increase in GCase protein levels with transport to the lysosomes and decrease of glucosylceramide and α-synuclein-p129 levels — Comprehensive study results to be presented at Michael J. Fox Foundation’s upcoming Innovating from Drug Discovery to the Clinic: Novel Approaches to PD Therapeutic Development webinar — IND-initiating study planned for Q4’21 BETHESDA, Md., Sept. 08, 2021 (GLOBE NEWSWIRE) — Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company focused on identifying and optimizing allosteric binding sites never before targeted in neurodegenerative diseases and lysosomal storage disorders, today announced topline data from the Company’s study,...

Continue reading

Cloud Gaming Market: Electronic Arts Inc. Collaborated with Google to Launch Five New EA Games on its Gaming Platform Stadia, reports Fortune Business Insights™

Key Companies Covered in Cloud Gaming Market Research Report are Microsoft Corporation, NVIDIA Corporation, Ubitus Inc., Vortex (RemoteMyApp Sp. z o.o.), Google Inc., Amazon Inc., Intel Corporation, Tencent, Sony Corporation, Blacknut, Playkey, Loudplay, Apple, Inc., Electronic Arts, Inc., Hatch Entertainment, Jump Gaming Inc. Pune, India, Sept. 08, 2021 (GLOBE NEWSWIRE) — The global cloud gaming market is set to gain traction from the increasing usage of smartphones. The GSMAi Report, for instance, declared that by 2025, around 80% of people will gain access to smartphones, while in 2019 there were approximately 5.2 billion smartphone connections worldwide. This information is given by Fortune Business Insights™ in a report, titled, “Cloud Gaming Market, 2021-2028.” As per the report, the market size is projected to grow from...

Continue reading

Invesco Ltd: Form 8.3 – Xeris Pharmaceutical Inc

                         Form 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MOREKEY INFORMATIONName of person dealing (Note 1) Invesco Ltd.Company dealt in Xeris Pharmaceuticals, Inc.Class of relevant security to which the dealings being disclosed relate (Note 2) Common Stock US98422L1070Date of dealing 07-9-2021INTERESTS AND SHORT POSITIONS(a)    Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)  Long Short  Number   (%) Number         (%)(1) Relevant securities 2,036,821         3.063%       (2) Derivatives (other than options)    (3) Options and agreements to purchase/sell    Total 2,036,821 3.063%  Interests...

Continue reading

VectivBio Appoints Scott Applebaum as Chief Legal Officer & Corporate Secretary

Biopharma veteran enhances VectivBio’s legal, regulatory and operational capabilities BASEL, Switzerland, Sept. 08, 2021 (GLOBE NEWSWIRE) — VectivBio Holding AG (“VectivBio”) (Nasdaq: VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, today announced the appointment of Scott Applebaum as Chief Legal Officer & Corporate Secretary. Mr. Applebaum brings over two decades of legal, regulatory and operational experience in the biopharmaceutical industry to VectivBio. “Scott has a great understanding of the legal and regulatory intricacies of the biotech and rare disease space,” said Luca Santarelli, M.D., Founder and CEO of VectivBio. “His knowledge and leadership will help guide us as we advance our Phase 3 trial of apraglutide in Short Bowel Syndrome with...

Continue reading

VSBLTY, HCL TECHNOLOGIES & TECH MAHINDRA AMONG FIVE COMPANIES CREATING NEW FIRM TO FOCUS ON LARGE IAAS PROJECTS

Philadelphia, PA, Sept. 08, 2021 (GLOBE NEWSWIRE) — VSBLTY Groupe Technologies Corp. (OTCQB: VSBGF) (CSE: VSBY) (Frankfurt 5VS) (“VSBLTY”), a leading software provider of security and retail analytics technology, announced it is one of the five founding partners of Austin GIS, a new company that will focus on large IaaS projects leveraging computer vision, machine learning and infrastructure. IaaS stands for Infrastructure as a Service and is emerging as an innovative and creative way to finance large IT infrastructure projects. HCL Technologies and Tech Mahindra are also founding investors, along with two additional participating firms, including a Fortune 500 company, that will be named later. The founding companies are investing $6 million USD in an initial seed round financing. HCL and Tech Mahindra are investing $1.25 million...

Continue reading

Pactiv Evergreen Revises Guidance for the Full Fiscal Year 2021

LAKE FOREST, Ill., Sept. 08, 2021 (GLOBE NEWSWIRE) — Pactiv Evergreen Inc. (NASDAQ: PTVE) (“Pactiv Evergreen” or the “Company”), today provided an update to its previous financial guidance. Pactiv Evergreen is revising the full fiscal year 2021 Adjusted EBITDA1 guidance to $550 million. Although the Company is seeing continued underlying volume recovery across all of our segments, profitability is expected to be negatively impacted by a number of significant external challenges. First, the continued increase in raw materials costs, particularly the cost of resins, which is now expected to remain at elevated levels throughout 2021, as well as increased transportation costs, has delayed our ability to recover these costs into 2022. Second, recent weather events including Tropical Storm Fred and resulting floods have slowed the recovery...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.